Literature DB >> 10050075

A new computerized biomechanical perfusion model for ex vivo study of fluid mechanical forces in intact conduit vessels.

L Gan1, L S Sjögren, R Doroudi, S Jern.   

Abstract

We have developed a new computerized biomechanical ex vivo perfusion system for intact conduit vessels in which a wide range of combinations of intraluminal pressure, fluid flow and shear stress could be set and maintained at target levels in mammalian conduit vessels under controlled metabolic conditions. Mean wall shear stress is calculated using the formula: Accuracy of the wall shear stress calculation was validated by ultrasonographic imaging of the vessel radius. In a series of simulation experiments, the hemodynamic homeostasis functions of the system were challenged by generating a wide range of vascular resistance in artificial vessels and by pharmacologically induced changes in vascular tone in intact human vessels. Despite rapid changes in vessel resistance, shear stress and pressure, or flow and pressure were maintained well at target levels. Shear- and pressure-stimulated production of the vasodilator prostaglandin E2 (PGE2) was used to validate the biological relevance of the model. PGE2 release was significantly more stimulated by high (25 dyn/cm2) compared to low (<4 dyn/cm2) shear (ANOVA, p = 0.012). High compared to low intraluminal pressure depressed the production of PGE2 (ANOVA, p = 0.019). In summary, the computerized perfusion model appears to offer new possibilities of investigating the complex interplay between fluid mechanics and the vascular wall.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10050075     DOI: 10.1159/000025627

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  1 in total

1.  Function and structure of pressurized and perfused porcine carotid arteries: effects of in vitro balloon angioplasty.

Authors:  Jop Perrée; Ton G van Leeuwen; Raphaella Kerindongo; Jos A E Spaan; Ed VanBavel
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.